Bridgefront Capital’s CVS Health CVS Stock Holding History

Bridgefront Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$806K	Sell	11,229 -6,842	-38%	-$527K	0.2%	164
2025 Q4	$1.43M	Buy	+18,071	New	+$1.42M	0.36%	73
2025 Q3	–	Sell	-6,847	Closed	-$472K	–	628
2025 Q2	$472K	Buy	+6,847	New	+$449K	0.13%	292
2025 Q1	–	Sell	-11,644	Closed	-$523K	–	671
2024 Q4	$523K	Buy	+11,644	New	+$653K	0.18%	196
2023 Q2	–	Sell	-23,183	Closed	-$1.72M	–	499
2023 Q1	$1.72M	Buy	23,183 +10,145	+78%	+$851K	1.05%	2
2022 Q4	$1.22M	Buy	13,038 +10,376	+390%	+$1M	0.85%	2
2022 Q3	$254K	Buy	+2,662	New	+$263K	0.26%	175
2021 Q3	–	Sell	-14,761	Closed	-$1.23M	–	414
2021 Q2	$1.23M	Buy	+14,761	New	+$1.21M	0.46%	26

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridgefront Capital's CVS Position: Q1 2026 in Review

Bridgefront Capital reduced its CVS Health (CVS) stake by 38% in Q1 2026, selling an estimated $527K and leaving 11,229 shares worth $806K. The position accounts for 0.2% of the portfolio, ranked #164.

Bridgefront Capital first reported a position in CVS in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.72M in Q1 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Bridgefront Capital held 11,229 shares of CVS Health worth $806K as of Q1 2026.
Bridgefront Capital sold 6,842 CVS Health shares in Q1 2026, an estimated $527K.
CVS Health made up 0.2% of Bridgefront Capital's portfolio in Q1 2026, its #164 holding.
Bridgefront Capital first reported a position in CVS Health in Q2 2021 and has held it in 8 quarters since.
Bridgefront Capital's CVS Health position peaked at $1.72M in Q1 2023.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.